← Leaderboards
Mark A Birrell
Thomas Jefferson University
$548,046
Attributed
$2,192,184
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $579.5K · FY2017–20$1M$750K$500K$250K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$2,192,184 · 1
By mechanism
R01$2,192,184 · 1
Top collaborators
- Joshua A Boyce4 shared
- Ramaswamy Krishnan4 shared
- Raymond B. Penn4 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Jeffrey L Benovic$31,875,251
- Raymond B. Penn$20,418,451
- Joannes B Hoek$23,581,570
- Paul A Janmey$17,822,534
- Richard Fishel$21,843,302
Others in their field
Other Emerging Leaders on “Cytokine”
- Thomas Denny · Duke University$22,999,550
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
- Gary Fanger · Rise Therapeutics, Llc$12,156,047
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$9,841,960
Research focus
CytokineDesignAirway EpitheliumCultured CellsAgonistAllergensAllergicAllergic InflammationCoughingAffectAirway RemodelingAsthmaBaseBlood CellsBronchoconstrictionCaviaCellsCell TypeCellularityAirway HyperresponsivenessCommunitiesComplementComplexDifferential Expression
Grant awards (4)
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2020 · HL
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2019 · HL
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2018 · HL
Optimizing EP receptor subtype targeting for asthma therapy$579,546
R01 · FY2017 · HL